Mutated WT1 has been already described in mesothelioma; interestingly, Park et al[27] reported a patient with PM that harbored a point mutation within the transactivation domain of WT1 gene, demonstrating that this variant conferred an activation of its transcriptional role. The gene discussed is WT1; the disease is mesothelioma.